Inactivation Of Type I IFN Jak-STAT Pathway In EBV Latency
Epstein-Barr Virus (EBV) latent infection is associated with a variety of lymphomas and carcinomas. Interferon (IFN) Regulatory Factors (IRFs) are a family of transcription factors, among which IRF7 is the “master” regulator of type I IFNs (IFN-I) that defends against invading viruses. Robust IFN-I...
Main Authors: | Ning, Shunbin, Wang, Ling |
---|---|
Format: | Others |
Published: |
Digital Commons @ East Tennessee State University
2016
|
Subjects: | |
Online Access: | https://dc.etsu.edu/etsu-works/6533 https://dc.etsu.edu/cgi/viewcontent.cgi?article=7784&context=etsu-works |
Similar Items
-
The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency
by: Lesley R. de Armas, et al.
Published: (2021-08-01) -
Viral and Cellular MicroRNAs in Regulation of EBV Latency and Oncogenesis
by: Wang, Ling, et al.
Published: (2017) -
Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway
by: Qianqian Yin, et al.
Published: (2021-09-01) -
JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology
by: Meredyth G. Ll Wilkinson, et al.
Published: (2021-09-01) -
Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists
by: Stephen B. Fleming
Published: (2016-06-01)